Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 6
Submit an article Journal homepage
252
Views
5
CrossRef citations to date
0
Altmetric
Letter to the editor

Recurrent Sympathetic Ophthalmia with Annular Choroidal Detachment after Pembrolizumab Treatment: A Case Report

Junwon Lee1 Department of Ophthalmology, Eye and ENT Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South KoreaView further author information
, MD, PhD,
Joo Youn Shin1 Department of Ophthalmology, Eye and ENT Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South Korea;2 Department of Ophthalmology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South KoreaView further author information
, MD,
Jihei Sara Lee1 Department of Ophthalmology, Eye and ENT Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South KoreaView further author information
, MD,
Sung Chul Lee1 Department of Ophthalmology, Eye and ENT Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South KoreaView further author information
, MD, PhD,
Min Hee Hong3 Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South KoreaView further author information
, MD, PhD &
Christopher Seungkyu Lee1 Department of Ophthalmology, Eye and ENT Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5054-9470View further author information
, MD, PhDORCID Icon
Pages 864-867 | Received 07 Feb 2019, Accepted 02 Apr 2019, Published online: 01 Jul 2019

References

  • Shih K, Arkenau HT, Infante JR. Clinical impact of checkpoint inhibitors as novel cancer therapies. Drugs. 2014;74:1993–2013. doi:10.1007/s40265-014-0305-6.
  • Syn NL, Teng MWL, Mok TSK, Soo RA. De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol. 2017;18:e731–e741. doi:10.1016/S1470-2045(17)30607-1.
  • Abdel-Rahman O, Oweira H, Petrausch U, et al. Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Rev Anticancer Ther. 2017;17:387–394. doi:10.1080/14737140.2017.1296765.
  • Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793–800. doi:10.1038/nm730.
  • Geng Q, Jiao P, Jin P, Su G, Dong J, Yan B. PD-1/PD-L1 inhibitors for immuno-oncology: from antibodies to small molecules. Curr Pharm Des. 2018;23:6033–6041. doi:10.2174/1381612823666171004120152.
  • Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: systemic indications and ophthalmic side effects. Retina. 2018;38:1063–1078. doi:10.1097/IAE.0000000000002181.
  • Zimmer L, Goldinger SM, Hofmann L, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016;60:210–225. doi:10.1016/j.ejca.2016.02.024.
  • Thomas M, Armenti ST, Ayres MB, Demirci H. Uveal effusion after immune checkpoint inhibitor therapy. JAMA Ophthalmol. 2018;136:553–556. doi:10.1001/jamaophthalmol.2018.0920.
  • Emens LA, Davis SL, Oliver SCN, et al. Association of cancer immunotherapy with acute macular neuroretinopathy and diffuse retinal venulitis. JAMA Ophthalmol. 2019;137:96–100.
  • Acaba-Berrocal LA, Lucio-Alvarez JA, Mashayekhi A, Ho AC, Dunn JP, Shields CL. Birdshot-like chorioretinopathy associated with pembrolizumab treatment. JAMA Ophthalmol. 2018;136:1205–1207. doi:10.1001/jamaophthalmol.2018.1851.
  • Conrady CD, Larochelle M, Pecen P, Palestine A, Shakoor A, Singh A. Checkpoint inhibitor-induced uveitis: a case series. Graefe‘S Arch Clin Exp Ophthalmol. 2018;256:187–191. doi:10.1007/s00417-017-3835-2.
  • Shah DN, Piacentini MA, Burnier MN, McLean IW, Nussenblatt RB, Chan CC. Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes. Ocul Immunol Inflamm. 1993;1:255–262. doi:10.3109/09273949309085026.
  • Jang M, Lee HJ, Jeong JH, Kim JY. Rare case of sympathetic ophthalmia with severe annular choroidal detachment. Can J Ophthalmol. 2019;54:e6–e10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.